CURRENT STATE OF DIAGNOSIS AND TREATMENT OF CARDIORENAL SYNDROME IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE: REVIEW
Cardiorenal syndrome in patients with ischemic chronic heart failure remains one of the most challenging problems in clinical cardiology and nephrology. Its significance is determined by the reciprocal interaction between cardiac and renal dysfunction, which increases the risk of hospitalization, worsens tolerance to evidence-based therapy and limits the achievement of target doses of prognostically important drugs. The aim of this review was to analyze current evidence on the diagnosis and treatment of cardiorenal syndrome in patients with ischemic chronic heart failure, focusing on publications from the last five years. Literature was searched in PubMed, Scopus, Web of Science, Cochrane Library, eLibrary, CyberLeninka and the Russian Science Citation Index for 2021-2026. Clinical guidelines, consensus documents, systematic reviews, meta-analyses, major randomized trials and Russian- language publications on chronic heart failure, chronic kidney disease, congestion assessment, renal biomarkers and contemporary therapy were included. Current evidence indicates that the diagnosis of cardiorenal syndrome should not rely only on serum creatinine and estimated glomerular filtration rate. A more justified approach combines albuminuria, natriuretic peptides, electrolytes, clinical and ultrasound signs of venous congestion, and response to diuretic therapy. Treatment should include individualized decongestion, preservation of guideline-directed heart failure therapy, use of sodium-glucose cotransporter 2 inhibitors and regular monitoring of renal function. Early detection of subclinical kidney injury, differentiation between functional creatinine rise and true kidney damage, and selection of treatment strategy in diuretic resistance remain insufficiently resolved. Key words: Cardio-Renal Syndrome; Heart Failure; Myocardial Ischemia; Renal Insufficiency, Chronic; Diagnosis; Therapeutics; Sodium-glucose cotransporter 2 inhibitors.
Сведения
- Опубликовано
- 2026 · Т. 16, № 2, С. 275-282
- Язык
- Английский
- ISSN
- 2414-0252
- Издатель
- «Институт последипломного образования в сфере здравоохранения Республики Таджикистан» при Министерстве здравоохранения и социальной защиты населения Республики Таджикистан
- Аффилиации
- Кафедра внутренних болезней №2 ГОУ «Таджикский государственный медицинский университет имени Абуали ибни Сино», г. Душанбе. Таджикистан